Hetrombopag

CAS No. 2114365-78-3

Hetrombopag( —— )

Catalog No. M13363 CAS No. 2114365-78-3

Hetrombopag is a potent, selective, orally-active Thrombopoietin (TPO) receptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 485 Get Quote
50MG 2507 Get Quote
100MG 3168 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Hetrombopag
  • Note
    Research use only, not for human use.
  • Brief Description
    Hetrombopag is a potent, selective, orally-active Thrombopoietin (TPO) receptor agonist.
  • Description
    Hetrombopag is a potent, selective, orally-active Thrombopoietin (TPO) receptor agonist; specifically stimulates proliferation and/or differentiation of human TPOR-expressing cells, including 32D-MPL and human hematopoietic stem cells, with low nanomolar EC50 values through stimulation of STAT, PI3K and ERK signalling pathways; specifically enhances the viability and promoted the growth of 32D-MPL cells in hollow fibres implanted in nude mice, exhibiting much higher potency than eltrombopag in vivo.Other Indication Phase 2 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    CD110
  • Recptor
    CD110
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    2114365-78-3
  • Formula Weight
    458.474
  • Molecular Formula
    C25H22N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMF : 6.25 mg/mL (13.63 mM)
  • SMILES
    CC1=C(C(=O)N(N1)C2=CC3=C(CCCC3)C=C2)N=NC4=CC=CC(=C4O)C5=CC=C(O5)C(=O)O
  • Chemical Name
    5-[(5E)-5-[[5-methyl-3-oxo-2-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-pyrazol-4-yl]hydrazinylidene]-6-oxocyclohexa-1,3-dien-1-yl]furan-2-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhou N, et al. Cardiovasc Drugs Ther. 2016 Dec;30(6):567-577. 2. Xie C, et al. J Cell Mol Med. 2018 Nov;22(11):5367-5377.
molnova catalog
related products
  • Lusutrombopag

    An orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist.

  • Hetrombopag

    Hetrombopag is a potent, selective, orally-active Thrombopoietin (TPO) receptor agonist.